Idiopathic generalized epilepsies: Which seizure type is more difficult to control?

Asadi‐Pooya, Ali A.; Farazdaghi, Mohsen

doi:10.1016/j.jocn.2023.06.011

Journal of Clinical Neuroscience

2023

DOI: 10.1016/j.jocn.2023.06.011

|View full text |Cite

Idiopathic generalized epilepsies: Which seizure type is more difficult to control?

Ali A. Asadi‐Pooya

Mohsen Farazdaghi

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 20 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Efficacy and Blood Levels of Lacosamide in Patients with Focal Epilepsy

Iwasaki,

Kobayashi,

Miyamoto

et al. 2024

JCM

View full text Add to dashboard Cite

Objectives: The aim of this paper is to analyze clinical targets for lacosamide (LCM) blood levels in patients with focal epilepsy. Referring to the LCM optimal range will encourage us to think about the importance and usefulness of measuring its blood levels. Methods: A total of 101 (45 female, 56 male) patients were treated with LCM. Blood sampling was performed 1 month after the start of oral medication (the levels reached a steady state) if the LCM treatment had been continued, and then 6 and 12 months after. The efficacy of LCM was evaluated by the reduction in the epileptic seizure rate (RR) at the time of blood sampling. The patients were classified as effective cases (seizure reduction rate ≥ 50%) and ineffective cases (<50%). The actual level, the calculated peak/trough levels, and the levels for each type of seizure were investigated. A statistical analysis was performed using Spearman’s rank correlation coefficient and the Wilcoxon signed-rank test. Results: A positive correlation was seen between blood levels and dosage (r = 0.446). However, the blood levels and RR showed no correlation. The blood levels were higher in effective cases than in ineffective cases at all time points (measurement p < 0.001, peak p = 0.013, trough p = 0.001). Because the range was set so that the effective and ineffective groups did not overlap, the optimal range of LCM was found to be 8.0–10.5 µg/mL. Conclusions: Measuring and calculating blood levels of LCM and adjusting the dosage to reach the optimal range are recommended. Moreover, the optimal range for LCM was determined as a therapeutic target.

show abstract

Efficacy and Blood Levels of Lacosamide in Patients with Focal Epilepsy

Iwasaki,

Kobayashi,

Miyamoto

et al. 2024

JCM

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Idiopathic generalized epilepsies: Which seizure type is more difficult to control?

Cited by 1 publication

References 20 publications

Efficacy and Blood Levels of Lacosamide in Patients with Focal Epilepsy

Efficacy and Blood Levels of Lacosamide in Patients with Focal Epilepsy

Contact Info

Product

Resources

About